Tango Therapeutics (TNGX) SEC Filings & 10K Form

$7.31
0.00 (0.00%)
(As of 04/22/2024 ET)

Recent Tango Therapeutics SEC Filings

DateFilerForm TypeView
04/17/2024
3:53 PM
Tango Therapeutics (Filer)
Form PRE 14A
04/08/2024
7:46 AM
Southpoint Capital Advisors LP (Filed by)
Tango Therapeutics (Subject)
Form SC 13G/A
03/18/2024
7:27 AM
Tango Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/18/2024
6:19 AM
Tango Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/18/2024
6:08 AM
Tango Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
4:52 PM
Tango Therapeutics (Issuer)
Third Rock Ventures GP IV, L.P. (Reporting)
Third Rock Ventures IV, L.P. (Reporting)
TRV GP IV, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
11:32 AM
Tango Therapeutics (Subject)
Third Rock Ventures IV, L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2024
8:49 AM
FMR LLC (Filed by)
Tango Therapeutics (Subject)
Form SC 13G/A
02/08/2024
8:04 PM
Crystal Adam (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
8:08 PM
Beckman Daniella (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
8:09 PM
Barry Douglas (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
8:14 PM
Tango Therapeutics (Issuer)
Weber Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2024
6:00 AM
Tango Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2023
6:29 AM
Tango Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2023
6:07 AM
Tango Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:49 PM
Crystal Adam (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2023
4:23 PM
BCTG Holdings, LLC (Filed by)
Tango Therapeutics (Subject)
Form SC 13D/A
10/17/2023
6:41 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
Form 4/A
10/17/2023
5:04 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2023
2:33 PM
EcoR1 Capital, LLC (Filed by)
Tango Therapeutics (Subject)
Form SC 13G/A
10/16/2023
2:42 PM
EcoR1 Capital, LLC (Reporting)
Tango Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/11/2023
8:22 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023
6:22 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
Form 4/A
10/10/2023
8:42 PM
MVA Investors, LLC (Reporting)
Tango Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2023
8:43 PM
Boxer Capital, LLC (Reporting)
Tango Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/21/2023
4:16 PM
EcoR1 Capital, LLC (Filed by)
Tango Therapeutics (Subject)
Form SC 13G
09/11/2023
11:15 PM
Tango Therapeutics (Filer)
Form EFFECT
09/11/2023
7:23 AM
FMR LLC (Filed by)
Tango Therapeutics (Subject)
Form SC 13G/A
09/01/2023
6:34 AM
Tango Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/30/2023
5:04 AM
Tango Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/24/2023
3:10 PM
Tango Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
08/22/2023
3:15 PM
Tango Therapeutics (Issuer)
Third Rock Ventures GP VI, L.P. (Reporting)
Third Rock Ventures VI, L.P. (Reporting)
TRV GP VI, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/21/2023
3:16 PM
Nextech Crossover I GP S.a r.l. (Filed by)
Tango Therapeutics (Subject)
Form SC 13G
08/16/2023
3:40 PM
BCTG Holdings, LLC (Filed by)
Tango Therapeutics (Subject)
Form SC 13D/A
08/15/2023
8:34 PM
Boxer Asset Management Inc. (Reporting)
Boxer Capital, LLC (Reporting)
Davis Aaron I. (Reporting)
LEWIS JOSEPH (Reporting)
MVA Investors, LLC (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2023
6:24 AM
Tango Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
6:57 AM
Tango Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2023
6:25 AM
Tango Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2023
8:36 PM
Borisy Alexis (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
8:39 PM
Calhoun Lesley Ann (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
8:40 PM
Rothenberg Mace (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
SHOCKING Crypto Leak… (Ad)

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.
06/08/2023
8:32 PM
Davis Aaron I. (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
8:33 PM
Peters Malte (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2023
8:34 PM
Huber Reid M (Reporting)
Tango Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
3:49 PM
Tango Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2023
6:31 AM
Tango Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2023
6:22 AM
Tango Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2023
3:47 PM
Tango Therapeutics (Filer)
Form ARS
04/24/2023
3:40 PM
Tango Therapeutics (Filer)
Form DEFA14A
04/24/2023
3:31 PM
Tango Therapeutics (Filer)
Form DEF 14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TNGX) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners